![Paul George Jenkins](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul George Jenkins
Chief Executive Officer at Cellesce Ltd.
Paul George Jenkins active positions
Companies | Position | Start | End |
---|---|---|---|
Cellesce Ltd.
![]() Cellesce Ltd. BiotechnologyHealth Technology Cellesce Ltd. develops bioprocessing technology for organoids. Its products include colorectal cancer organoids and organoids of other human organs. The company was founded in 2013 and is headquartered in Cardiff, the United Kingdom. | Director/Board Member | 2020-07-31 | - |
Chief Executive Officer | 2020-07-31 | - |
Career history of Paul George Jenkins
Former positions of Paul George Jenkins
Companies | Position | Start | End |
---|---|---|---|
Phoqus Pharmaceuticals Plc
![]() Phoqus Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Phoqus Pharmaceuticals Plc develops pharmaceutical products. It's product Chronocort that helps to treat the patients with cortisol deficiency such as congenital adrenal hyperplasia and Addison's diseases. The company was founded in 1998 and is located in West Malling, UK. | Corporate Officer/Principal | - | - |
West Pharmaceutical Services Group Ltd.
![]() West Pharmaceutical Services Group Ltd. Financial ConglomeratesFinance Part of West Pharmaceutical Services, Inc., West Pharmaceutical Services Group Ltd. functions as an investment holding British company. The company is based in St. Austell, UK. | Corporate Officer/Principal | - | - |
Adjuvantix Ltd.
![]() Adjuvantix Ltd. BiotechnologyHealth Technology Adjuvantix Ltd. engages in the research and development of vaccines for the treatment of cancer and infectious diseases. Its initial vaccine development targets include prostate cancer, lymphoma and TB. The company's products include ADX40-TB, ADX40-prostate cancer and ADX40-lymphoma. Adjuvantix was founded by Andrew John William Heath on October 28, 1999 and is headquartered in Sheffield, the United Kingdom. | Director/Board Member | - | - |
Chief Executive Officer | 2009-10-15 | - |
Training of Paul George Jenkins
London Business School | Masters Business Admin |
Statistics
International
United Kingdom | 6 |
Operational
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Corporate Officer/Principal | 2 |
Sectoral
Health Technology | 4 |
Consumer Services | 2 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 4 |
---|---|
Adjuvantix Ltd.
![]() Adjuvantix Ltd. BiotechnologyHealth Technology Adjuvantix Ltd. engages in the research and development of vaccines for the treatment of cancer and infectious diseases. Its initial vaccine development targets include prostate cancer, lymphoma and TB. The company's products include ADX40-TB, ADX40-prostate cancer and ADX40-lymphoma. Adjuvantix was founded by Andrew John William Heath on October 28, 1999 and is headquartered in Sheffield, the United Kingdom. | Health Technology |
Phoqus Pharmaceuticals Plc
![]() Phoqus Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Phoqus Pharmaceuticals Plc develops pharmaceutical products. It's product Chronocort that helps to treat the patients with cortisol deficiency such as congenital adrenal hyperplasia and Addison's diseases. The company was founded in 1998 and is located in West Malling, UK. | Health Technology |
West Pharmaceutical Services Group Ltd.
![]() West Pharmaceutical Services Group Ltd. Financial ConglomeratesFinance Part of West Pharmaceutical Services, Inc., West Pharmaceutical Services Group Ltd. functions as an investment holding British company. The company is based in St. Austell, UK. | Finance |
Cellesce Ltd.
![]() Cellesce Ltd. BiotechnologyHealth Technology Cellesce Ltd. develops bioprocessing technology for organoids. Its products include colorectal cancer organoids and organoids of other human organs. The company was founded in 2013 and is headquartered in Cardiff, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Paul George Jenkins
- Experience